Immupharma PLC has received a notification of major holdings from Lanstead Capital Investors LP. The reason for the notification is an event changing the breakdown of voting rights. Lanstead Capital Investors LP now holds 21.93% of the voting rights attached to Immupharma's ordinary shares, representing a decrease from their previous position of 22.28%. The total number of voting rights of Immupharma is 416,437,265. The notification does not provide any information on the financial instruments held by Lanstead Capital Investors LP. The notification was completed in London on September 13, 2023.